Showing 8591-8600 of 23064 results for "".
Inter-Professional Education: Working Together as a Team
https://reachmd.com/programs/villanova_health_summit/inter-professional-education-working-together-team/8114/Dr. Brian McDonough talks with Lawrence Sherman about the importance of inter-professional education.A Poster is Worth a Thousand Words: Tips for Presenting Posters
https://reachmd.com/programs/speaking-of/poster-worth-thousand-words-tips-presenting-posters/8172/Karen Friedman describes what you can do to prepare an interesting poster presentation and maximize your audience reach.Weekly Check-up | March 21st 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-march-21st-2016/8015/Welcome to the Weekly Check-up on ReachMD for the week of March 21st, 2016. Check out this week's programs: Pandemic: Tracking Contagions, from Cholera to Ebola and Beyond Navigating the Changing Landscape of Diabetes Pulmonary Nodules at a Glance New National Screening Data on ComparatWhen it's More than Just Heartburn: Preventing Respiratory Complications of Reflux Disease
https://reachmd.com/programs/primary-care-today/when-its-more-than-just-heartburn-preventing-respiratory-complications-reflux-disease/7893/Respiratory complications of GERD are surprisingly common, particularly in patients experiencing silent, asymptomatic reflux for long periods of time. Yet the frequently subclinical nature of this disease progression is especially difficult to detect. How can clinicians better identify this rising iUnderstanding Value-Based Care: Dr. Neel Shah, Founder of Costs of Care
https://reachmd.com/programs/conversations-on-health-care/understanding-value-based-care-dr-neel-shah-founder-costs-care/7814/This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Neel Shah, Assistant Professor of Obstetrics and Gynecology at Harvard Medical School and Founder of Costs of Care, a global NGO dedicated to helping delivery systems provide better care at lower costs. He's also the co-author of UndControlling and Eliminating Neglected Tropical Diseases Worldwide: The END Fund's Mission
https://reachmd.com/programs/villanova_health_summit/controlling-and-eliminating-neglected-tropical-diseases-worldwide-end-funds-mission/7704/Joining host Dr. Matt Birnholz is Sarah Marchal Murray, Chief Operating Officer at The END Fund, a private philanthropic initiative dedicated to controlling and eliminating neglected tropical diseases (NTDs). Over 1.4 billion people globally are affected by one or more of the most common NTDs, incluStoned: A Doctor's Case for Medical Marijuana
https://reachmd.com/programs/book-club/stoned-a-doctors-case-for-medical-marijuana/7616/No substance on earth is as hotly debated as marijuana. Opponents claim it’s dangerous, addictive, carcinogenic, and a gateway to serious drug abuse. Conversely, fans claim it as a wonder drug, treating cancer, anorexia, AIDS, chronic pain, glaucoma, arthritis, migraines, PTSD, and insomnia. In StonA New Era of Scientific Research: Updates from the National Genome Research Institute
https://reachmd.com/programs/conversations-on-health-care/new-era-scientific-research-updates-national-genome-research-institute/7555/This week, Mark and Margaret speak with Dr. Eric Green, Director of the National Human Genome Research Institute at the National Institutes of Health, the world's largest organization dedicated solely to genomics research. Dr. Green was on the team that mapped the human genome and talks about new inUpdates from the "Pulmonary Pipeline" of COPD Drug Developments
https://reachmd.com/programs/clinicians-roundtable/updates-pulmonary-pipeline-copd-drug-developments/7413/In today's clinical practice, there is no appropriate "one size fits all" treatment approach for COPD. But while this progressive trend toward personalized medicine standards helps optimize COPD care for each patient, the cost-to-benefit ratio for drug development changes as COPD evolves from one diPath Toward a Single Shot Ebola Vaccine
https://reachmd.com/programs/world-medical-news/path-toward-single-shot-ebola-vaccine/7322/A single-shot experimental vaccine for Ebola made headlines in the news after successful administration and protection in macaque monkeys.